| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065751 Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 03/17/2011 | US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 03/17/2011 | US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065724 Compounds that modulate intracellular calcium |
| 03/17/2011 | US20110065711 Substituted triazolo-pyridazine derivatives |
| 03/17/2011 | US20110065700 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065699 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110065675 Azo dye related small molecule modulators of protein-protein interactions |
| 03/17/2011 | US20110065658 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
| 03/17/2011 | US20110065651 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 03/17/2011 | US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes |
| 03/17/2011 | US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110064813 Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet |
| 03/17/2011 | US20110064809 Scaffolds |
| 03/17/2011 | US20110064803 Nanoparticulate and controlled release compositions comprising vitamin k2 |
| 03/17/2011 | US20110064786 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells |
| 03/17/2011 | US20110064784 Method for producing a three-dimensional macroporous filament construct based on phase inversion and construct thereby obtained |
| 03/17/2011 | US20110064782 Methods and compositions for tissue regeneration |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof |
| 03/17/2011 | US20110064717 Homing endonuclease genes and their targets |
| 03/17/2011 | US20110064703 Bone substitute compositions, methods of preparation and clinical applications |
| 03/17/2011 | CA2773940A1 Nutritional compositions including exogenous vitamin k2 |
| 03/17/2011 | CA2773494A1 Actriib antagonists and dosing and uses thereof |
| 03/17/2011 | CA2772656A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units |
| 03/17/2011 | CA2772069A1 Osteolysis treatment |
| 03/16/2011 | EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293816A1 Methods for the treatment of rheumatoid arthritis |
| 03/16/2011 | EP2293807A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293775A2 Hydrogel capable of containing and conveying cells |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1631266B1 A method of treating degenerative disc disease |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN1850227B Medicine for treating bone fracture |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985033A Compound traditional Chinese medicine for treating stubborn diseases |
| 03/16/2011 | CN101985014A Pawpaw wine capable of relaxing tendons |
| 03/16/2011 | CN101985013A Chinese herbal medicine for treating rheumatic arthritis |
| 03/16/2011 | CN101985008A Hyperplasia-removing liquid |
| 03/16/2011 | CN101984983A Lamiophlomis rotata extract, medicine composition containing same and quality control method thereof |
| 03/16/2011 | CN101984882A Health-care medicinal pillow for preventing cervical spondylosis |
| 03/16/2011 | CN101698058B Medicine for treating chronic arthralgia and preparation method thereof |
| 03/16/2011 | CN101647878B Traditional Chinese medicine preparation for treating rheumatism and numbness |
| 03/16/2011 | CN101618200B Externally-applied plaster for specially treating cervical spondylosis and preparation method thereof |
| 03/16/2011 | CN101618026B Meloxicam tablet, production technology and purposes thereof |
| 03/16/2011 | CN101590185B Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof |
| 03/16/2011 | CN101575335B Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/16/2011 | CN101485808B Method for measuring naringin content in preparation for reunion of bone |
| 03/16/2011 | CN101485778B Capsule prescription containing prepared rehmannia root and oyster and preparation method thereof |
| 03/16/2011 | CN101347606B Chinese medicine plaster for treating rheumatism osteonosus and preparation method |
| 03/16/2011 | CN101264273B Orally-administered pure Chinese medicine for treating bone fracture and osteosporosis and preparation thereof |
| 03/16/2011 | CN101199833B Compound essential oil of releasing arthritis ache |
| 03/16/2011 | CN101199778B Compound medicament for treating synovitis |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906518 Therapeutic compounds |
| 03/15/2011 | US7906330 Two cell population comprising chondrocyte precursors and human embryonic stem cells |
| 03/15/2011 | CA2591053C Pyrimidinone compounds and preparation and use thereof |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2471814C Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/15/2011 | CA2289119C Methods for treating inflammation and inflammatory diseases using padprt inhibitors |
| 03/11/2011 | CA2772929A1 Methods for treating, diagnosing, and monitoring rheumatoid arthritis |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011028062A2 Composition for increasing height |
| 03/10/2011 | WO2011028044A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 03/10/2011 | WO2011028043A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 03/10/2011 | WO2011027850A1 Bone regeneration agent including gelatin |
| 03/10/2011 | WO2011026362A1 Use of cobrotoxin for manufacturing a medicament for the treatment of arthritis |